Envista/$NVST
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Envista
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Ticker
$NVST
Sector
Primary listing
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
12,300
ISIN
US29415F1049
Website
Envista Metrics
BasicAdvanced
$3.3B
-
-$6.54
0.98
-
Price and volume
Market cap
$3.3B
Beta
0.98
52-week high
$22.68
52-week low
$14.22
Average daily volume
2.3M
Financial strength
Current ratio
2.118
Quick ratio
1.684
Long term debt to equity
46.425
Total debt to equity
51.398
Interest coverage (TTM)
3.52%
Profitability
EBITDA (TTM)
269.6
Gross margin (TTM)
54.77%
Net profit margin (TTM)
-44.90%
Operating margin (TTM)
6.02%
Effective tax rate (TTM)
-3.04%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
1.57%
Return on equity (TTM)
-31.33%
Valuation
Price to revenue (TTM)
1.354
Price to book
1.11
Price to tangible book (TTM)
40.89
Price to free cash flow (TTM)
12.657
Free cash flow yield (TTM)
7.90%
Free cash flow per share (TTM)
155.40%
Growth
Revenue change (TTM)
-2.30%
Earnings per share change (TTM)
817.21%
3-year revenue growth (CAGR)
-0.31%
3-year earnings per share growth (CAGR)
50.41%
What the Analysts think about Envista
Analyst ratings (Buy, Hold, Sell) for Envista stock.
Bulls say / Bears say
Envista's recent product launches, including a new CBCT platform and enhanced software for the DEXIS intraoral scanner, demonstrate a commitment to innovation that could drive future revenue growth. (nasdaq.com)
The company's strategic investments in its North American implant business have shown positive developments, suggesting potential for market share expansion. (markets.businessinsider.com)
Analysts project a 21% earnings growth for Envista in the coming year, indicating strong future profitability. (marketbeat.com)
Mizuho initiated coverage of Envista with an 'Underperform' rating and a $20 price target, reflecting concerns about the company's future performance. (nasdaq.com)
Envista's Q3 2024 gross margin contracted by 475 basis points to 52.8%, indicating increased cost pressures and potential profitability challenges. (nasdaq.com)
Analysts have been regularly downgrading their EPS expectations for Envista over the past 12 months, suggesting a deteriorating earnings outlook. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
Envista Financial Performance
Revenues and expenses
Envista Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Envista stock?
Envista (NVST) has a market cap of $3.3B as of June 30, 2025.
What is the P/E ratio for Envista stock?
The price to earnings (P/E) ratio for Envista (NVST) stock is 0 as of June 30, 2025.
Does Envista stock pay dividends?
No, Envista (NVST) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Envista dividend payment date?
Envista (NVST) stock does not pay dividends to its shareholders.
What is the beta indicator for Envista?
Envista (NVST) has a beta rating of 0.98. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.